Literature DB >> 34618582

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.

Nicolò Pernigoni1,2, Elena Zagato1,2, Arianna Calcinotto1,2, Martina Troiani1,2, Ricardo Pereira Mestre3, Bianca Calì1,2, Giuseppe Attanasio1,2, Jacopo Troisi4, Mirko Minini1,2, Simone Mosole1,2, Ajinkya Revandkar1,2, Emiliano Pasquini1,2, Angela Rita Elia1,2, Daniela Bossi1,2, Andrea Rinaldi1,2, Pasquale Rescigno5, Penny Flohr6, Joanne Hunt6, Antje Neeb6, Lorenzo Buroni6, Christina Guo6, Jonathan Welti6, Matteo Ferrari3, Matteo Grioni7, Josée Gauthier8, Raad Z Gharaibeh8, Anna Palmisano9,10, Gladys Martinetti Lucchini11, Eugenia D'Antonio3, Sara Merler12,13, Marco Bolis1,2,14, Fabio Grassi15, Antonio Esposito9,10, Matteo Bellone7, Alberto Briganti16,17, Maria Rescigno18,19, Jean-Philippe Theurillat1,2, Christian Jobin8,20,21, Silke Gillessen2,3, Johann de Bono6, Andrea Alimonti1,2,12,22.   

Abstract

The microbiota comprises the microorganisms that live in close contact with the host, with mutual benefit for both counterparts. The contribution of the gut microbiota to the emergence of castration-resistant prostate cancer (CRPC) has not yet been addressed. We found that androgen deprivation in mice and humans promotes the expansion of defined commensal microbiota that contributes to the onset of castration resistance in mice. Specifically, the intestinal microbial community in mice and patients with CRPC was enriched for species capable of converting androgen precursors into active androgens. Ablation of the gut microbiota by antibiotic therapy delayed the emergence of castration resistance even in immunodeficient mice. Fecal microbiota transplantation (FMT) from CRPC mice and patients rendered mice harboring prostate cancer resistant to castration. In contrast, tumor growth was controlled by FMT from hormone-sensitive prostate cancer patients and Prevotella stercorea administration. These results reveal that the commensal gut microbiota contributes to endocrine resistance in CRPC by providing an alternative source of androgens.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34618582     DOI: 10.1126/science.abf8403

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  32 in total

1.  Prostate Cancer Risk Connection to Immunity, Hormones, and the Microbiome.

Authors:  Jeffrey S Bland
Journal:  Integr Med (Encinitas)       Date:  2021-12

2.  A microbiome short circuit in prostate cancer.

Authors:  Katie Kingwell
Journal:  Nat Rev Drug Discov       Date:  2021-12       Impact factor: 84.694

3.  Glucosylated nanoparticles for the oral delivery of antibiotics to the proximal small intestine protect mice from gut dysbiosis.

Authors:  Guorong Zhang; Qin Wang; Wanyin Tao; Wei Jiang; Eran Elinav; Yucai Wang; Shu Zhu
Journal:  Nat Biomed Eng       Date:  2022-07-07       Impact factor: 29.234

Review 4.  Chemical Compounds of Berry-Derived Polyphenols and Their Effects on Gut Microbiota, Inflammation, and Cancer.

Authors:  Abdelhakim Bouyahya; Nasreddine El Omari; Naoufal El Hachlafi; Meryem El Jemly; Maryam Hakkour; Abdelaali Balahbib; Naoual El Menyiy; Saad Bakrim; Hanae Naceiri Mrabti; Aya Khouchlaa; Mohamad Fawzi Mahomoodally; Michelina Catauro; Domenico Montesano; Gokhan Zengin
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

Review 5.  Emerging Proteins in CRPC: Functional Roles and Clinical Implications.

Authors:  Piaoping Kong; Lingyu Zhang; Zhengliang Zhang; Kangle Feng; Yiwen Sang; Xiuzhi Duan; Chunhua Liu; Tao Sun; Zhihua Tao; Weiwei Liu
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

6.  Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis.

Authors:  Weibo Zhong; Kaihui Wu; Zining Long; Xumin Zhou; Chuanfan Zhong; Shuo Wang; Houhua Lai; Yufei Guo; Daojun Lv; Jianming Lu; Xiangming Mao
Journal:  Microbiome       Date:  2022-06-16       Impact factor: 16.837

7.  Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma.

Authors:  Yang Chen; Junjie Ma; Yunze Dong; Ziyu Yang; Na Zhao; Qian Liu; Wei Zhai; Junhua Zheng
Journal:  Front Microbiol       Date:  2022-07-04       Impact factor: 6.064

Review 8.  Prostate cancer in transgender women: considerations for screening, diagnosis and management.

Authors:  Fionnuala Crowley; Meredith Mihalopoulos; Simita Gaglani; Ashutosh K Tewari; Che-Kai Tsao; Miroslav Djordjevic; Natasha Kyprianou; Rajveer S Purohit; Dara J Lundon
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

Review 9.  The gut microbiota can be a potential regulator and treatment target of bone metastasis.

Authors:  Kelly F Contino; Hariom Yadav; Yusuke Shiozawa
Journal:  Biochem Pharmacol       Date:  2022-01-15       Impact factor: 5.858

10.  Alterations and Correlations of Gut Microbiota and Fecal Metabolome Characteristics in Experimental Periodontitis Rats.

Authors:  Lan Wu; Jie Han; Jia-Yan Nie; Tong Deng; Cheng Li; Cheng Fang; Wen-Zhong Xie; Shuang-Ying Wang; Xian-Tao Zeng
Journal:  Front Microbiol       Date:  2022-04-14       Impact factor: 6.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.